
    
      To assess the safety and feasibility of an in situ single injection of a high dose of
      autologous bone marrow-derived, in vitro expanded Mesenchymal stem cells, and its
      contribution to the resolution of the early stages of avascular osteonecrosis of the femoral
      head.
    
  